Delegations of Authority and Organization; Food and Drug Administration

The Food and Drug Administration (FDA) is amending the general redelegations of authority from the Commissioner of Food and Drugs to other officers of FDA. On June 20, 1999, the Commissioner of Food and Drugs restructured FDA "to create a more streamlined and efficient Office of the Commissioner that will provide leadership without compromising programmatic effectiveness." In this restructuring, organizational components were abolished and established and functions and personnel were transferred. Therefore, FDA is updating the delegations of authority regulations to reflect these changes and to delegate authority to positions in newly established components. FDA is also updating some position titles that may have been affected by previous reorganizations.